O-GlcNAcylation: a novel therapeutic target for brain disorders As discussed above, O-GlcNAcylation is implicated in various CNS disorders, including neurodevelopmental disorders, neurodegenerative diseases, psychiatric diseases, and CNS injuries
Research has revealed that the complex modulates the expression of over 4,000 mammalian genes, with particularly pronounced effects on genes involved in tissue repair, antioxidant defense, and inflammatory resolution
Monitor Your Progress Monitoring your symptoms and overall health becomes essential once you implement changes to your treatment plan
Research Findings The research foundation for Epithalon is substantial, though much of this work has been conducted in Russia and published primarily in Russian or Eastern European journals, with less representation in mainstream Western scientific literature
These studies provide some evidence of elevated glutamine levels in ACC/mPFC, especially in the early phase of illness